Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 58, Issue 51, Pages 18641-18646Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201910815
Keywords
chemodynamic therapy; molybdenum polyoxometalate; NIR-II; photoacoustic imaging; photothermal therapy
Categories
Funding
- NNSF of China [61525402, 61775095, 51803091, 61935004]
- Jiangsu Provincial key research and development plan [BE2017741]
- Six talent peak innovation team in Jiangsu Province [TD-SWYY-009]
Ask authors/readers for more resources
To overcome the current limitations of chemodynamic therapy (CDT), a Mo2C-derived polyoxometalate (POM) is readily synthesized as a new CDT agent. It permits synergistic chemodynamic and photothermal therapy operating in the second near-infrared (NIR-II) biological transparent window for deep tissue penetration. POM aggregated in an acidic tumor micro-environment (TME) whereby enables specific tumor targeting. In addition to the strong ability to produce singlet oxygen (O-1(2)) presumably via Russell mechanism, its excellent photothermal conversion enhances the CDT effect, offers additional tumor ablation modality, and permits NIR-II photoacoustic imaging. Benefitting from the reversible redox property of molybdenum, the theranostics based on POM can escape from the antioxidant defense system. Moreover, combining the specific responsiveness to TME and localized laser irradiation, side-effects shall be largely avoided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available